Back

Association between Sodium-Glucose Cotransporter-2 inhibitors and depression in chronic heart failure: A Tunisian propensity score-matched cohort study

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 16 Multidisciplinary Interventions HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Mr Aymen Noamen

Military Hospital of Tunis, Tunis (Tunisia)

6 More presentations in this session

Presentation thumbnail
Enhancing initiation and uptitration of guideline-directed medical therapy among inpatients with heart failure with reduced ejection fraction
Mrs R. Hall (Tauranga, NZ)
Abstract Slides Video
Presentation thumbnail
Impact of yoga therapy on long-term outcomes in heart failure patients using functional and echocardiographic parameters
Doctor A. Singh (Manipal, IN)
Abstract Slides Video
Presentation thumbnail
Differences in the organization and management of heart failure between departments with and without accredited units of cardiology and internal medicine in Spain
Doctor G. Alvaro (Oviedo, ES)
Abstract Slides Video
Presentation thumbnail
Therapeutic optimization score for patients with heart failure and reduced ejection fraction in a low-middle income country: Design and score implementation for the OPTIMAL-HF trial
Ms L. Burgos (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Evaluation of patient satisfaction with prescribing heart failure pharmacist medicine optimisation clinics and whether this is impacted by the method of clinic delivery
Ms G. Campbell (Buntingford, GB)
Abstract Slides Video

Access the full session

Session thumbnail
Chronic heart failure - treatment 16

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Presentation
The role of masqued anxiety and depression in the evolution of chronic heart failure disease
thumbnail
Congress Presentation
Real-world use of empaglifozin and dapaglifozin in patients with HEART failure
thumbnail
Congress Presentation
The use of SGLT-2 inhibitors and hemoconcentration in patients with heart failure

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources